Although clinical trials are considered a “gold standard” in identifying the efficacy of treatments, real-world data help address unmet needs in colorectal cancer.
Eric L. Grogan, MD, MPH
Advertisement
Articles by Eric L. Grogan, MD, MPH
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on OncLive
1
Allogeneic CD19 CAR NK-Cell Therapy Induces Durable Disease Control in Waldenstrom Lymphoma
2
FDA Approval of Epcoritamab-Based Triplet Challenges Prior Standards for R/R Follicular Lymphoma
3
Evolving Strategies in the Management of HR+, HER2– Metastatic Breast Cancer
4
The OncFive: Top Oncology Articles for the Week of 1/11
5